Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biochem Biophys Res Commun ; 452(3): 593-9, 2014 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-25181346

RESUMEN

Because multi-wall carbon nanotubes (MWCNTs) have asbestos-like shape and size, concerns about their pathogenicity have been raised. Contaminated metals of MWCNTs may also be responsible for their toxicity. In this study, we employed high-temperature calcined fullerene nanowhiskers (HTCFNWs), which are needle-like nanofibers composed of amorphous carbon having similar sizes to MWCNTs but neither metal impurities nor tubular structures, and investigated their ability to induce production a major proinflammatory cytokine IL-1ß via the Nod-like receptor pyrin domain containing 3 (NLRP3)-containing flammasome-mediated mechanism. When exposed to THP-1 macrophages, long-HTCFNW exhibited robust IL-1ß production as long and needle-like MWCNTs did, but short-HTCFNW caused very small effect. IL-1ß release induced by long-HTCFNW as well as by long, needle-like MWCNTs was abolished by a caspase-1 inhibitor or siRNA-knockdown of NLRP3, indicating that NLRP3-inflammasome-mediated IL-1ß production by these carbon nanofibers. Our findings indicate that the needle-like shape and length, but neither metal impurities nor tubular structures of MWCNTs were critical to robust NLRP3 activation.


Asunto(s)
Proteínas Portadoras/genética , Fulerenos/farmacología , Interleucina-1beta/metabolismo , Macrófagos/efectos de los fármacos , Nanofibras/toxicidad , Nanotubos de Carbono/toxicidad , Clorometilcetonas de Aminoácidos/farmacología , Proteínas Portadoras/antagonistas & inhibidores , Proteínas Portadoras/metabolismo , Caspasa 1/genética , Caspasa 1/metabolismo , Inhibidores de Caspasas/farmacología , Línea Celular , Fulerenos/química , Expresión Génica , Calor , Humanos , Inflamasomas/efectos de los fármacos , Inflamasomas/metabolismo , Interleucina-1beta/biosíntesis , Macrófagos/citología , Macrófagos/metabolismo , Proteína con Dominio Pirina 3 de la Familia NLR , Nanofibras/química , Nanotubos de Carbono/química , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/metabolismo
2.
Forensic Toxicol ; 42(2): 142-151, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38294576

RESUMEN

PURPOSE: NPB-22 (quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate), Adamantyl-THPINACA (N-(1-adamantantyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indazole-3-carboxamide), and CUMYL-4CN-B7AICA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H- pyrrolo[2,3-b]pyridine-3-carboxamide), synthetic cannabinoids were evaluated in terms of CB1 (cannabinoid receptor type 1) and CB2 (cannabinoid receptor type 2) activities, and their biological effects when inhaled similar to cigarettes were examined. METHODS: The half maximal effective concentration values of the aforementioned synthetic cannabinoids at the CB1 and CB2 were investigated using [35S]guanosine-5'-O-(3-thio)-triphosphate binding assays. In addition, their biological effects were evaluated using the inhalation exposure test with mice. The smoke generated was recovered by organic solvents in the midget impingers, and the thermal degradation compounds of the smoke components were identified and quantified using a liquid chromatography-photo diode array detector. RESULTS: NPB-22 and Adamantyl-THPINACA had equivalent CB1 activity in in vitro assays. Meanwhile, NPB-22 had a weaker biological effect on some items on the inhalation exposure test than Adamantyl-THPINACA. When analyzing organic solvents in the midget impingers, it was revealed that NPB-22 was degraded to 8-quinolinol and pentyl indazole 3-carboxylic acid by combustion. In addition, these degradation compounds did not have CB1 activity. CONCLUSION: It was estimated that the biological effects of NPB-22 on the inhalation exposure test weakened because it underwent thermal degradation by combustion, and the resultant degradation compounds did not have any CB1 activity in vitro.


Asunto(s)
Cannabinoides , Indazoles , Receptor Cannabinoide CB1 , Receptor Cannabinoide CB2 , Animales , Indazoles/química , Indazoles/farmacología , Cannabinoides/química , Cannabinoides/farmacología , Receptor Cannabinoide CB1/metabolismo , Receptor Cannabinoide CB1/agonistas , Ratones , Receptor Cannabinoide CB2/metabolismo , Receptor Cannabinoide CB2/agonistas , Masculino , Calor , Administración por Inhalación , Estabilidad de Medicamentos , Adamantano/análogos & derivados , Adamantano/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA